One year in review
Systemic sclerosis: one year in review 2023
M. Di Battista1, G. Lepri2, V. Codullo3, M. Da Rio4, E. Fiorentini5, A. Della Rossa6, S. Guiducci7
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.
- Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Italy.
- Rheumatology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. a.dellarossa@ao-pisa.toscana.it
- Department of Experimental and Clinical Medicine, Division of Rheumatology, University of Florence, Italy.
CER16759
2023 Vol.41, N°8
PI 1567, PF 1574
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 37199215 [PubMed]
Received: 15/04/2023
Accepted : 20/04/2023
In Press: 17/05/2023
Published: 03/08/2023
Abstract
Systemic sclerosis is a rare and chronic connective tissue disease resulting from an intricate pathogenesis and is expressed in very heterogeneous clinical manifestations. Every year many studies try to unravel and shed new insight into the pathogenesis, organ involvement and treatment of this complex and severe disease. We herein provide an overview of the most relevant studies published in the literature in 2022.
